Clarke and colleagues found that only cells with a CD44+/CD24low/−ESA+ phenotype had the ability to induce a new tumor with full phenotypic diversity [9]; in turn, the tumor could be sequentially propagated. The gene discussed is CD44; the disease is neoplasm.